Tracking non-relapse mortality after CAR T cell therapy

被引：0
|
作者：
Blumenberg, Viktoria [1 ,2 ]
Maus, Marcela V. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
NATURE MEDICINE | 2024年 / 30卷 / 09期
关键词：
LYMPHOMA;
D O I：
10.1038/s41591-024-03212-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Infections account for the highest number of non-relapse-related deaths after CAR T cell therapy, underscoring the necessity for clinical risk-mitigating strategies and a deeper understanding of CAR T cell-related cytopenia.
引用
收藏
页码：2413 / 2414
页数：2
相关论文
共 50 条
  • [21] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Masamitsu Yanada
    Naoyuki Uchida
    Tatsuo Ichinohe
    Takahiro Fukuda
    Junya Kanda
    Yoshinobu Kanda
    Yoshiko Atsuta
    Hideki Nakasone
    Bone Marrow Transplantation, 2021, 56 : 1720 - 1722
  • [22] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Yanada, Masamitsu
    Uchida, Naoyuki
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Kanda, Junya
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Nakasone, Hideki
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1720 - 1722
  • [23] Infections Drive Non-Relapse Mortality Following CAR-T Therapy across Disease Entities and CAR Products - a Meta-Analysis of Clinical Trials and Real-World Studies
    dos Santos, David M. Cordas
    Tix, Tobias
    Rejeski, Kai
    BLOOD, 2023, 142
  • [24] Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma
    Negishi, Shuto
    Girsch, James H.
    Siegler, Elizabeth L.
    Bezerra, Evandro D.
    Miyao, Kotaro
    Sakemura, R. Leo
    FRONTIERS IN PEDIATRICS, 2024, 11
  • [25] Effects of socio-economic status and gender on non-relapse mortality after allogeneic stem cell transplant
    Yanovsky, Asya Varshavsky
    Egleston, Brian L.
    Shestovska, Yuliya
    Ahr, Katya
    Mandzhieva, Dzhirgala
    Senchak, Jordan
    O'Brien, Jenny
    Styler, Michael
    Khanal, Rashmi
    Abdelmessieh, Peter
    Fung, Henry C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Easix-1yearas a Prognostic Index for Late Non-Relapse Mortality after Allogenichematopoietic Cell Transplantation
    Takeda, Rui Carrie
    Shibasaki, Yasuhiko
    Katagiri, Takayuki
    Fuse, Kyoko
    Sone, Hirohito
    Masuko, Masayoshi
    BLOOD, 2021, 138
  • [27] A SIMPLIFIED SCORING SYSTEM TO PREDICT DAY 100 NON-RELAPSE MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Basu, S. K.
    Liesveld, J. L.
    Trawick, D. R.
    Fernandez, D.
    Nichols, D.
    Fisher, S. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 20 - 20
  • [28] Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
    Dreyzin, Alexandra
    Rankin, Alexander W.
    Luciani, Katia
    Gavrilova, Tatyana
    Shah, Nirali N.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (07) : 745 - 763
  • [29] Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study
    Gong, Zimu
    Umoru, Godsfavour
    Monge, Jorge
    Shah, Nishi
    Mohyuddin, Ghulam Rehman
    Radhakrishnan, Sabarinath Venniyil
    Chakraborty, Rajshekhar
    Rasche, Leo
    Schinke, Carolina
    D'Souza, Anita
    Mohan, Meera
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [30] Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study
    Zimu Gong
    Godsfavour Umoru
    Jorge Monge
    Nishi Shah
    Ghulam Rehman Mohyuddin
    Sabarinath Venniyil Radhakrishnan
    Rajshekhar Chakraborty
    Leo Rasche
    Carolina Schinke
    Anita D’Souza
    Meera Mohan
    Blood Cancer Journal, 14
12345